DE GIOVANNI, CARLA
DE GIOVANNI, CARLA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Carla De Giovanni; Carla Degiovanni; C. D. Giovanni
2011: the immune hallmarks of cancer
2011-01-01 F. Cavallo; C. De Giovanni; P. Nanni; G. Forni; P. Lollini
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins
2010-01-01 E. Quaglino; C. Mastini; A. Amici; C. Marchini; M. Iezzi; S. Lanzardo; C. De Giovanni; M. Montani; P.-L. Lollini; G. Masucci; G. Forni; F. Cavallo
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
2005-01-01 Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani P; Forni G; Calogero RA.
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome
2009-01-01 C. De Giovanni; G. Nicoletti; A. Palladini; S. Croci; L. Landuzzi; A. Antognoli; A. Murgo; A. Astolfi; S. Ferrini; M. Fabbi; A.M. Orengo; A. Amici; M. L. Penichet; L. Aurisicchio; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini.
Alterations in folate-dependent one-carbon metabolism as colon cell transition from normal to cancerous
2019-01-01 Asante, I.; Chui, D.; Pei, H.; Zhou, E.; De Giovanni, C.; Conti, D.; Louie, S.
Antimetastatic activity of a preventive cancer vaccine.
2007-01-01 P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S. Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini.
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the ApcMin mouse model in vivo.
2009-01-01 S. Sale; I.L. Fong; C. De Giovanni; L. Landuzzi; K. Brown; W.P. Steward; A.J. Gescher
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
2004-01-01 DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L.
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
2019-01-01 De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luigi; Nanni, Patrizia
Cancer biology, what we know and what we don't know.
2006-01-01 P. Nanni; C. De Giovanni; P.-L. Lollini
Cancer immunoprevention
2005-01-01 P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
2019-01-01 De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Nicoletti, Giordano; Ruzzi, Francesca; Amici, Augusto; Croci, Stefania; Nanni, Patrizia; Lollini, Pier-Luigi
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
2004-01-01 QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S.; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F.
Delivery of CD44shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ mice.
2009-01-01 S. Misra; V.C. Hascall; C. De Giovanni; R.R. Markwald; S. Ghatak
Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment
2014-01-01 L. Iommarini;I. Kurelac;M. Capristo;M. A. Calvaruso;V. Giorgio;C. Bergamini;A. Ghelli;P. Nanni;C. De Giovanni;V. Carelli;R. Fato;P. L. Lollini;M. Rugolo;G. Gasparre;A. M. Porcelli
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
2021-01-01 Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Giusti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
2004-01-01 Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F.
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role.
2006-01-01 A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. Lollini; L. Landuzzi; P. Nanni
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
2021-01-01 Giusti, Veronica; Ruzzi, Francesca; Landuzzi, Lorena; Ianzano, Marianna L; Laranga, Roberta; Nironi, Elena; Scalambra, Laura; Nicoletti, Giordano; De Giovanni, Carla; Olivero, Martina; Arigoni, Maddalena; Calogero, Raffaele; Nanni, Patrizia; Palladini, Arianna; Lollini, Pier-Luigi
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells
2007-01-01 S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Giovanni.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 2011: the immune hallmarks of cancer | F. Cavallo; C. De Giovanni; P. Nanni; G. Forni; P. Lollini | 2011-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins | E. Quaglino; C. Mastini; A. Amici; C. Marchini; M. Iezzi; S. Lanzardo; C. De Giovanni; M. Montani...; P.-L. Lollini; G. Masucci; G. Forni; F. Cavallo | 2010-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. | Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani... P; Forni G; Calogero RA. | 2005-01-01 | INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome | C. De Giovanni; G. Nicoletti; A. Palladini; S. Croci; L. Landuzzi; A. Antognoli; A. Murgo; A. Ast...olfi; S. Ferrini; M. Fabbi; A.M. Orengo; A. Amici; M. L. Penichet; L. Aurisicchio; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini. | 2009-01-01 | HUMAN GENE THERAPY | - | 1.01 Articolo in rivista | - |
| Alterations in folate-dependent one-carbon metabolism as colon cell transition from normal to cancerous | Asante, I.; Chui, D.; Pei, H.; Zhou, E.; De Giovanni, C.; Conti, D.; Louie, S. | 2019-01-01 | JOURNAL OF NUTRITIONAL BIOCHEMISTRY | - | 1.01 Articolo in rivista | - |
| Antimetastatic activity of a preventive cancer vaccine. | P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S.... Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the ApcMin mouse model in vivo. | S. Sale; I.L. Fong; C. De Giovanni; L. Landuzzi; K. Brown; W.P. Steward; A.J. Gescher | 2009-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. | DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P.... L. | 2004-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model | De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luig...i; Nanni, Patrizia | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | TSA cancers w suppl.pdf; cancers-11-01889-s001.zip |
| Cancer biology, what we know and what we don't know. | P. Nanni; C. De Giovanni; P.-L. Lollini | 2006-01-01 | - | Bononia University Press | 2.01 Capitolo / saggio in libro | - |
| Cancer immunoprevention | P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni | 2005-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Cancer Vaccines Co-Targeting HER2/Neu and IGF1R | De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Nicoletti, Gio...rdano; Ruzzi, Francesca; Amici, Augusto; Croci, Stefania; Nanni, Patrizia; Lollini, Pier-Luigi | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | IGF1R vax Cancers-11-00517 (1).pdf; cancers-11-00517-s001.pdf |
| Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. | QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S....; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F. | 2004-01-01 | THE JOURNAL OF CLINICAL INVESTIGATION | - | 1.01 Articolo in rivista | - |
| Delivery of CD44shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ mice. | S. Misra; V.C. Hascall; C. De Giovanni; R.R. Markwald; S. Ghatak | 2009-01-01 | THE JOURNAL OF BIOLOGICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
| Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment | L. Iommarini;I. Kurelac;M. Capristo;M. A. Calvaruso;V. Giorgio;C. Bergamini;A. Ghelli;P. Nanni;C.... De Giovanni;V. Carelli;R. Fato;P. L. Lollini;M. Rugolo;G. Gasparre;A. M. Porcelli | 2014-01-01 | HUMAN MOLECULAR GENETICS | - | 1.01 Articolo in rivista | - |
| Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft | Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Gi...usti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi | 2021-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | PDX Breast Sci Rep small.pdf |
| Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. | Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M...; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F. | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. | A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. L...ollini; L. Landuzzi; P. Nanni | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression | Giusti, Veronica; Ruzzi, Francesca; Landuzzi, Lorena; Ianzano, Marianna L; Laranga, Roberta; Niro...ni, Elena; Scalambra, Laura; Nicoletti, Giordano; De Giovanni, Carla; Olivero, Martina; Arigoni, Maddalena; Calogero, Raffaele; Nanni, Patrizia; Palladini, Arianna; Lollini, Pier-Luigi | 2021-01-01 | ONCOGENESIS | - | 1.01 Articolo in rivista | HER-2 loss Oncogenesis.pdf; 41389_2021_360_MOESM1_ESM.pdf |
| Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells | S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Gio...vanni. | 2007-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |